Assure Announces Reverse Stock Split to support Continued Listing on NASDAQ
Assure Holdings announced a reverse stock split at a ratio of 18:1, effective July 9, 2024. This move aims to comply with NASDAQ's minimum bid price requirement. Post-split, the share count will reduce from approximately 10.6 million to about 589,017, with the stock trading under the same symbol 'IONM'. Fractional shares will be rounded up, and proportional adjustments will be made to all convertible securities. The total number of authorized shares will decrease to 13,888,888. Shareholders' percentage ownership and rights remain largely unchanged, with Computershare managing the exchange process.
- Reverse stock split will help the company comply with NASDAQ's minimum bid price requirement.
- Share price is expected to increase mechanically due to the 18:1 ratio.
- Total authorized shares will be reduced to 13,888,888, potentially making the stock more attractive to investors.
- Reverse stock split reduces the number of outstanding shares from approximately 10.6 million to about 589,017, which may create significant market adjustments.
Insights
The reverse stock split by Assure Holdings Corp. is a strategic move primarily aimed at meeting the NASDAQ's minimum bid price requirement. This is important for maintaining the company's listing on NASDAQ, which is important for liquidity and investor confidence. A reverse split consolidates the shares, increasing the price per share without affecting the overall market capitalization. In this case, each 18 shares of the company's common stock will be converted into one share.
From a financial perspective, the reverse split will reduce the total number of outstanding shares from approximately 10,602,306 to around 589,017. This means that while the share price will increase, the total market cap remains unchanged. Retail investors might find the higher per-share price more appealing, potentially reducing volatility associated with penny stocks. It's essential to note that reverse splits do not inherently change the company's valuation or fundamentals.
However, reverse stock splits can sometimes be perceived negatively by the market as they may suggest that the company is struggling to maintain its stock price above the required threshold for NASDAQ listing. Investors should closely monitor the company's performance post-split to gauge the effectiveness of this move in supporting the stock price.
In terms of market perception, reverse stock splits are often viewed with a degree of skepticism. They are primarily employed by companies seeking to avoid delisting due to low stock prices. While effective in raising the nominal share price, they do not address the underlying issues that may have led to the decline in the first place.
For retail investors, this consolidation might make the stock price appear more stable and fewer in number, which can sometimes attract new investors who prefer to hold fewer, higher-priced shares. However, the company's fundamentals remain unchanged and the move does not provide any immediate operational or financial benefits.
It's also worth noting that the proportional ownership and voting power of shareholders will remain unchanged, except for minor adjustments due to the rounding of fractional shares. This aspect is important for investors to understand that their overall stake in the company will not be diluted by this action.
DENVER, July 03, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it will effect a reverse stock split (the “Reverse Stock Split”) of its shares of common stock,
Assure’s common stock is expected to begin trading on the NASDAQ Capital Market on a split-adjusted basis when the market opens on July 9, 2024, meaning that each eighteen (18) pre-split shares will represent one (1) post-split share and the share price is expected to increase mechanically in proportion to the 18:1 ratio. Assure’s common stock will continue to trade under its existing symbol “IONM”. The new CUSIP number for the common stock following the Reverse Stock Split will be 04625J402.
The Reverse Stock Split is primarily intended to bring the Company into compliance with the minimum bid price requirement for maintaining the listing of its common stock on the NASDAQ Capital Market and to make the bid price more attractive to investors.
As a result of the 18:1 Reverse Stock Split, the total number of shares of common stock authorized by the Company under its Articles of Incorporation will be reduced from 250,000,000 shares of common stock, par value
The Reverse Stock Split will affect all issued and outstanding shares of common stock. All outstanding options, restricted stock awards, warrants, preferred stock and convertible notes and other securities entitling their holders to purchase or otherwise receive shares of common stock will be adjusted as a result of the Reverse Stock Split by decreasing the number of shares acquirable pursuant to the ratio of 18:1 and increasing the exercise or conversion price, as applicable, by the same ratio, as required by the terms of each such security. The number of shares of common stock available to be awarded under the Company’s equity incentive plans will also be proportionately adjusted.
As of July 3, 2024, the Company had approximately 10,602,306 shares of common stock issued and outstanding, and after the Reverse Stock Split, the Company will have approximately 589,017 shares of common stock issued and outstanding.
Immediately after the Reverse Stock Split, each stockholder’s percentage ownership interest in the Company and proportional voting power will remain virtually unchanged, except for minor changes and adjustments that will result from rounding fractional shares into whole shares, as applicable. The rights and privileges of the holders of shares of common stock will be substantially unaffected by the Reverse Stock Split.
The Company’s transfer agent, Computershare Trust Company, N.A. (“Computershare”), will serve as exchange agent for the Reverse Stock Split and will provide instructions to stockholders of record regarding the Reverse Stock Split. Unless otherwise requested by the stockholder, Computershare will be issuing all of the post-split shares in paperless, “book-entry” form, and unless otherwise requested by the stockholder, Computershare will hold the shares in an account set up for the stockholder. All book-entry or other electronic positions representing issued and outstanding shares of our common stock will be automatically adjusted. Those stockholders holding our common stock in “street name” will receive instructions from their brokers. For assistance from Computershare please call 1 (800) 546-5141.
About Assure Holdings
Assure Holdings Corp. is a provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic and ear, nose and throat surgeries. Assure employs highly trained technologists that provide a direct point of contact in the operating room. Physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure communicating in real-time with the surgeon and technologist. Accredited by The Joint Commission, Assure’s mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the Company’s website at www.assureneuromonitoring.com.
Forward-Looking Statements
This news release may contain “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements may generally be identified by the use of the words “anticipates,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “estimates," “potential,” “target,” or “continue” and variations or similar expressions. Forward-looking statements include, but are not limited to, management’s expectations regarding the increase in procedures, and other similar statements. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks include risks regarding our patient volume or cases not growing as expected, or decreasing, which could impact revenue and profitability; unfavorable economic conditions could have an adverse effect on our business; risks related to increased leverage resulting from incurring additional debt; the policies of health insurance carriers may affect the amount of revenue we receive; our ability to successfully market and sell our products and services; we may be subject to competition and technological risk which may impact the price and amount of services we can sell and the nature of services we can provide; regulatory changes that are unfavorable in the states where our operations are conducted or concentrated; our ability to comply and the cost of compliance with extensive existing regulation and any changes or amendments thereto; changes within the medical industry and third-party reimbursement policies and our estimates of associated timing and costs with the same; our ability to adequately forecast expansion and the Company’s management of anticipated growth; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our annual report on Form 10-K filed on April 26, 2024, and with the Canadian securities regulators and available on the Company’s profiles on EDGAR at www.sec.gov and SEDAR at www.sedar.com, which risks and uncertainties are incorporated herein by reference. Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.
Investor Contact
Brett Maas, Managing Principal, Hayden IR
ionm@haydenir.com
(646) 536-7331
FAQ
What is the effective date of Assure Holdings' reverse stock split?
Why is Assure Holdings conducting a reverse stock split?
What will happen to Assure Holdings' stock symbol after the reverse stock split?
How will the reverse stock split affect the number of outstanding shares of Assure Holdings?
What adjustments will be made to Assure Holdings' convertible securities due to the reverse stock split?
